SMTL ID : 4fm7.1

Crystal Structure of BACE with Compound 14g

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.56 Å

Oligo State

monomer

Ligands

1 x 0UP: 4-{[(5R,7S)-1-(3-fluorophenyl)-3,7-dimethyl-2,2-dioxido-2-thia-1,3,8-triazaspiro[4.5]dec-8-yl]methyl}-2-(propan-2-yloxy)phenol(Non-covalent)

0UP.1: 17 residues within 4Å: Chain A: G.15, Q.16, G.17, L.34, D.36, Y.75, T.76, Q.77, G.78, K.79, K.111, F.112, I.114, W.119, I.122, G.234, T.235 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.34, A:Y.75, A:Y.75, A:F.112, A:I.114, A:W.119, A:I.122 Hydrogen bonds: A:T.76, A:Q.77, A:F.112 Water bridges: A:T.76, A:R.239, A:R.239 Salt bridges: A:D.36, A:D.232

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: D.135, H.400, H.401, H.402 No protein-ligand interaction detected (PLIP) ZN.3: 2 residues within 4Å: Chain A: H.400, H.402 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:H.400, A:H.402

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brodney, M.A. et al., Spirocyclic sulfamides as beta-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors. J.Med.Chem. (2012)

Release Date

2012-10-03

Peptides

Beta-secretase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-secretase 1

Related Entries With Identical Sequence